Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Pathophysiology

What is Cancer of Unknown Primary?

Transforming Cancer Care through Genomic Testing

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Prognosis

Hot vs Cold: the differences between tumor types

CDK9 and Cancer

Cancer History

Cutaneous Manifestations of Internal Malignancy

Acidosis and Tumor Progression

Secondary Lung Cancer

See more featured articles »

TARDIS: The Improved Method of Detecting Breast Cancer

Living with Cancer Pain

Cancer Prevention: Lowering your Risk

What is Immunochemotherapy?

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Investigating the Molecular Mechanisms of Cancer

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Why are Cancer Cell Lines Useful?

Cancer Pain Management

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Myc Mutations and Cancer

Insight into Cancer Vaccines

Using Biomarkers to Detect Cancer

What Causes Cancer?

Microfluidic cancer treatment screen combined with flow cytometry

What is the Tumor Microenvironment?

Cancer Glossary

British Pioneers in Cancer Biology

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Diagnosis

Assay for Monitoring and Treating Malignant Brain Tumors

The Cancer Cell Surface Proteome as a Therapeutic Target

Pediatric Cancer

Cancer Symptoms

Hypoxia Markers and Their Importance

Extracellular Vesicles as Floating Cancer Biomarkers

What is Merkel Cell Carcinoma?

What is Cancer?

Exploiting Enzymes in Cancer Diagnosis and Therapy

Is Cancer a Metabolic Disorder?

What is Tumorigenesis?

Cancer Pain

Effects of Social and Economic Deprivation on Cancer Mortality

The Effects of Cancer on Family Life

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cancer Management

Cancer Screening Considerations: Balancing the Benefits and Risks

Insights into Oncofertility

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Overview of Cell Viability and Cytotoxicity

The Biochemistry of Breast Cancer Screening

Cancer Epidemiology

Cancer Research

Caring for a Loved One with Cancer

Cancer Classification

Secondary Brain Cancer

What Role do Biobanks Play in Cancer Research?

Targeted Cancer Therapies

Latest Cancer News and Research

BATF2: A novel tumor suppressor silenced by glutamine in head and neck cancer

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to researchers from The University of Texas MD Anderson Cancer Center.

7 Jan 2026

Brazilian study shows liquid biopsies can expedite lung cancer care

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment.

7 Jan 2026

Cornell-developed nanoparticles improve cancer immunotherapy effectiveness

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the effectiveness of cancer immunotherapy, according to a new study led by Weill Cornell Medicine and Cornell Engineering researchers.

7 Jan 2026

Replenishing mitochondria significantly reduces chronic nerve pain, research shows

For millions living with nerve pain, even a light touch can feel unbearable. Scientists have long suspected that damaged nerve cells falter because their energy factories known as mitochondria don't function properly.

7 Jan 2026

Newly discovered molecule could be a game-changer in the fight against deadly fungi

Fungal infections kill millions of people each year, and modern medicine is struggling to keep up. But researchers at McMaster University have identified a molecule that may help turn the tide — butyrolactol A, a chemical compound that targets a deadly, disease-causing fungi called Cryptococcus neoformans.

7 Jan 2026

Breakthrough treatment for advanced prostate cancer could eliminate severe side effects

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving therapy.

7 Jan 2026

Novel approach uncovers possible drugs based on specific cellular targets for treating glioblastoma

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor.

7 Jan 2026

Pitavastatin shows pomise in overcoming chemotherapy resistance in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy.

7 Jan 2026

MD Anderson and SOPHiA GENETICS join forces to accelerate data-driven cancer care

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS' AI-powered analytics with MD Anderson's clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice.

7 Jan 2026

Higher intake of food preservatives linked to increased risk of type 2 diabetes

Higher consumption of food preservatives, widely used in industrially processed foods and beverages to extend their shelf life, has been linked to an increased risk of type 2 diabetes.

7 Jan 2026

Newly discovered molecules accelerate the removal of immune-modulating enzyme

Cells have a remarkable housekeeping system: proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in the cellular recycling machinery.

7 Jan 2026

Homeless shelters for seniors pop up, catering to older adults’ medical needs

Just outside Salt Lake City sits an old, two-story, brick hotel. It's been given new life as a homeless shelter for seniors. The Medically Vulnerable People shelter — or MVP shelter, as it's known — is for people 62 and older or for younger adults with chronic health issues.

7 Jan 2026

Nuclera eProtein Discovery System installed at leading universities in Taiwan

Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through its benchtop eProtein Discovery™ System, today announced that it has completed the first installations of eProtein Discovery in Asia, with systems now operational at the Department of Pharmacy and the Department of Chemistry at the National Taiwan University (NTU) College of Medicine and the Center for Bioscience and Biotechnology and Department of Chemical Engineering at the National Cheng Kung University (NCKU).

7 Jan 2026

Inside the battle for the future of addiction medicine

Elyse Stevens had a reputation for taking on complex medical cases. People who'd been battling addiction for decades. Chronic-pain patients on high doses of opioids. Sex workers and people living on the street.

7 Jan 2026

Low-dose megestrol strengthens hormone therapy in ER-positive breast cancer

Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving treatment adherence in the PIONEER trial.

7 Jan 2026

Enveda’s third asset to the clinic with US FDA IND clearance: What it means for Inflammatory Bowel Disease

Enveda, a multi-asset clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life’s chemistry, has announced that the US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for ENV-6946.

From Hanson Wade Group - 4th Precision Medicine in Inflammatory Bowel Disease Summit 6 Jan 2026

A single immune protein may help explain why kidney and heart disease often develop together

This review synthesizes clinical, genetic, and mechanistic evidence showing that suPAR and related uPAR fragments are strongly associated with kidney, cardiovascular, and metabolic disease risk. It highlights suPAR as a stable biomarker of innate immune activation with potential pathogenic roles, while underscoring major gaps in assay standardization and therapeutic validation.

6 Jan 2026

New database targets hidden causes of chronic urinary tract infections in children

A new database targeting chronic urinary tract infections (UTIs) – a long-overlooked condition that may begin in childhood – is set to help researchers uncover why millions of women and girls worldwide suffer from infections that defy treatment and stump microbiologists.

6 Jan 2026

New breakthrough could modernize treatment for glioblastoma

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could modernize treatment for glioblastoma, a fast-growing and deadly form of brain cancer.

6 Jan 2026

ASTRO rebrands research foundation to accelerate innovation in radiation oncology

The American Society for Radiation Oncology (ASTRO) announced today that it rebranded its research foundation, formerly the Radiation Oncology Institute (ROI), as Speed of Light – The ASTRO Foundation, marking a new chapter in ASTRO's commitment to advancing research and improving patient care in radiation oncology.

6 Jan 2026